Healthcare provider profile · identity verified

Rudolf Haider, MD

Family Practice · SEAL BEACH, CA · NPI 1740249069

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	286	87
Losartan Potassium	Losartan Potassium	233	75
Levothyroxine Sodium	Levothyroxine Sodium	185	56
Amlodipine Besylate	Amlodipine Besylate	139	40
Tamsulosin Hcl	Tamsulosin Hcl	95	32
Lisinopril	Lisinopril	84	29
Metoprolol Tartrate	Metoprolol Tartrate	83	28
Pantoprazole Sodium	Pantoprazole Sodium	82	25
Furosemide	Furosemide	78	30
Metoprolol Succinate	Metoprolol Succinate	78	22
Eliquis	Apixaban	73	20
Gabapentin	Gabapentin	73	20
Rosuvastatin Calcium	Rosuvastatin Calcium	71	20
Omeprazole	Omeprazole	69	23
Escitalopram Oxalate	Escitalopram Oxalate	67	19
Simvastatin	Simvastatin	66	18
Metformin Hcl	Metformin Hcl	58	26
Hydrochlorothiazide	Hydrochlorothiazide	54	18
Alendronate Sodium	Alendronate Sodium	53	16
Trazodone Hcl	Trazodone Hcl	52	11
Sildenafil Citrate	Sildenafil Citrate	50	suppressed
Finasteride	Finasteride	47	13
Allopurinol	Allopurinol	46	13
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Lovastatin	Lovastatin	44	13
Atenolol	Atenolol	43	15
Synthroid	Levothyroxine Sodium	43	12
Diclofenac Sodium	Diclofenac Sodium	36	16
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	20
Hydralazine Hcl	Hydralazine Hcl	32	11
Donepezil Hcl	Donepezil Hcl	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Potassium Chloride	Potassium Chloride	25	11
Alprazolam	Alprazolam	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Sertraline Hcl	Sertraline Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	18
Albuterol Sulfate Hfa	Albuterol Sulfate	20	13
Azithromycin	Azithromycin	20	19
Digoxin	Digoxin	20	suppressed
Famotidine	Famotidine	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Lidocaine	Lidocaine	19	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Prednisone	Prednisone	17	17
Spironolactone	Spironolactone	17	suppressed
Temazepam	Temazepam	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Estradiol	Estradiol	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error